Gil Hakim
2018
In 2018, Gil Hakim earned a total compensation of $3.9M as Former President at UroGen Pharma Ltd., a 187% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,043,753 |
|---|---|
| Salary | $330,791 |
| Other | $2,481,675 |
| Total | $3,856,219 |
Hakim received $2.5M in other compensation, accounting for 64% of the total pay in 2018.
Hakim also received $1M in option awards and $330.8K in salary.
Rankings
In 2018, Gil Hakim's compensation ranked 2,914th out of 14,244 executives tracked by ExecPay. In other words, Hakim earned more than 79.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,914 out of 14,244 | 80th |
Division Manufacturing | 1,070 out of 5,765 | 81st |
Major group Chemicals And Allied Products | 370 out of 2,128 | 83rd |
Industry group Drugs | 303 out of 1,817 | 83rd |
Industry Pharmaceutical Preparations | 230 out of 1,391 | 84th |
Source: SEC filing on April 26, 2019.
Hakim's colleagues
We found six more compensation records of executives who worked with Gil Hakim at UroGen Pharma Ltd. in 2018.
2018
Ron Bentsur
UroGen Pharma Ltd.
Chief Executive Officer
2018
Stephen Mullennix
UroGen Pharma Ltd.
Chief Financial Officer
2018
Gary Titus
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Mark Schoenberg
UroGen Pharma Ltd.